Cash Flow Kaken Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
19,435.00
9,796.00
6,817.00
13,885.00
18,657.00
26,592.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
6,758.00
-6,359.00
2,338.00
-1,499.00
-630.00
5,574.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
29,780.00
2,577.00
9,253.00
13,336.00
14,380.00
27,468.00
Cash Flow from Investing Activities
-19,650.00
-5,854.00
-2,627.00
-7,888.00
-1,644.00
-2,528.00
Cash Flow from Financing Activities
-5,369.00
-5,658.00
-6,990.00
-8,129.00
-8,752.00
-10,173.00
Net Cash Inflow / Outflow
4,761.00
-8,935.00
-364.00
-2,681.00
3,984.00
14,767.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kaken Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
19435
-6414
25,849.00
403.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
6758
-328
7,086.00
2160.37%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
29780
-5486
35,266.00
642.84%
Cash Flow from Investing Activities
-19650
-9874
-9,776.00
-99.01%
Cash Flow from Financing Activities
-5369
9736
-15,105.00
-155.15%
Net Cash Inflow / Outflow
4761
-5560
10,321.00
185.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
64
-64.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 1,055.61% vs -72.15% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
29,780.00
2,577.00
1,055.61%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
